- Europe's drug regulator has found a probable link between heart inflammation and COVID-19 vaccines made by Pfizer(NYSE:PFE)and Moderna(NASDAQ:MRNA),Reuters reports.
- Heart conditions myocarditis and pericarditis must be listed as possible side effects of the two mRNA vaccines, the EMA said.
- This included an in-depth review of 145 cases of myocarditis and 138 cases of pericarditis in Europe among people who received BioNTech's(NASDAQ:BNTX)Comirnaty and 19 cases in those who received Moderna's Spikevax.
- The EMA panel has also advised people with a history of a rare blood disorder should avoid Johnson & Johnson'(NYSE:JNJ)single-shot coronavirus vaccine.
- Three cases of capillary leak syndrome(CLS) were reviewed who had received J&J shot. One of those affected had a history of CLS and two of them subsequently died.
- Last month, U.S. health officials reported possible link betweenheart inflammation condition and mRNA-based COVID-19 shots.
- Earlier in June, the EMA asked CLS to be added as aside effect from AstraZeneca's(NASDAQ:AZN) jab.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments